The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries
Sheng-En Chou,1 Cheng-Shyuan Rau,2 Wei-Ti Su,1 Ching-Hua Tsai,1 Shiun-Yuan Hsu,1 Ching-Hua Hsieh1 1Department of Trauma Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan; 2Department of Neurosurgery, Kaohsiung Chang Gung Memorial Hospita...
Main Authors: | Chou SE, Rau CS, Su WT, Tsai CH, Hsu SY, Hsieh CH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-02-01
|
Series: | Risk Management and Healthcare Policy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-association-of-albumin-bilirubin-albi-grade-with-mortality-risk-in-peer-reviewed-fulltext-article-RMHP |
Similar Items
-
Predictive Power of the Albumin–Bilirubin Score for Hepatotoxicity in Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma
by: Jihyeon Joo, et al.
Published: (2023-07-01) -
Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
by: Jia-I Liao, et al.
Published: (2023-01-01) -
Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy
by: Wei-Fan Hsu, et al.
Published: (2022-10-01) -
Clinical Role of Newly Developed ALBI and mALBI Grades for Treatment of Hepatocellular Carcinoma
by: Atsushi Hiraoka, et al.
Published: (2020-10-01) -
On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
by: Hung-Wei Wang, et al.
Published: (2021-07-01)